📰 A Contract Testing Development News
A Contract Testing Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from A Contract Testing Development. Real-time updates on events, politics, business and more.
March 8, 2022
/PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced the launch of Tetracycline-Enabled Self-Silencing...
March 8, 2022
PHILADELPHIA, March 7, 2022 /PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced the laun...
March 8, 2022
/PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced the launch of Tetracycline-Enabled Self-Silencing...
March 8, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
March 8, 2022
TESSA™ technology provides a scalable process for manufacturing gene therapies, accelerating the production of large quantities of therapeutic DNA required to treat patients in need.
March 8, 2022
TESSA™ technology provides a scalable process for manufacturing gene therapies, accelerating the production of large quantities of therapeutic DNA required to treat patients in need New data published in Nature Communications supports the benefits of this technology PHILADELPHIA, March 8, 2022 /PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced the launch...